• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Breast Cancer Among Women With Type 2 Diabetes.

作者信息

Suissa Melanie, Yin Hui, Yu Oriana H Y, Wong Stephanie M, Azoulay Laurent

机构信息

Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada.

Centre for Clinical Epidemiology, Lady Davis Institute, Montreal, Canada.

出版信息

Diabetes Care. 2021 Jan;44(1):e9-e11. doi: 10.2337/dc20-1073. Epub 2020 Nov 6.

DOI:10.2337/dc20-1073
PMID:33158946
Abstract
摘要

相似文献

1
Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Breast Cancer Among Women With Type 2 Diabetes.钠-葡萄糖协同转运蛋白2抑制剂与2型糖尿病女性患乳腺癌的短期风险
Diabetes Care. 2021 Jan;44(1):e9-e11. doi: 10.2337/dc20-1073. Epub 2020 Nov 6.
2
Sodium-Glucose Cotransporter Inhibitors for the Treatment of Type 1 Diabetes Mellitus.钠-葡萄糖共转运蛋白抑制剂治疗 1 型糖尿病。
Clin Drug Investig. 2020 Nov;40(11):991-1000. doi: 10.1007/s40261-020-00949-9.
3
Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus.心力衰竭风险分层与钠-葡萄糖共转运蛋白 2 抑制剂在 2 型糖尿病患者中的疗效。
Circulation. 2019 Nov 5;140(19):1569-1577. doi: 10.1161/CIRCULATIONAHA.119.042685. Epub 2019 Aug 31.
4
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.钠-葡萄糖共转运蛋白 2 抑制剂用于预防 2 型糖尿病患者的心血管事件：系统评价和荟萃分析。
J Am Heart Assoc. 2020 Feb 4;9(3):e014908. doi: 10.1161/JAHA.119.014908. Epub 2020 Jan 29.
5
Effects of sodium glucose co-transporter 2 inhibitors on the kidney.钠-葡萄糖协同转运蛋白2抑制剂对肾脏的影响。
Diab Vasc Dis Res. 2018 Sep;15(5):375-386. doi: 10.1177/1479164118783756. Epub 2018 Jul 2.
6
Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Non-Diabetic Chronic Kidney Disease.钠-葡萄糖共转运蛋白 2 抑制剂在非糖尿病慢性肾脏病患者中的应用。
Adv Ther. 2021 May;38(5):2201-2212. doi: 10.1007/s12325-021-01735-5. Epub 2021 Apr 16.
7
[Short-term Glucose Lowering Effects of Sodium-glucose Cotransporter 2 Inhibitors Confirmed by Flash Glucose Monitoring in Two Outpatients with Type 1 Diabetes].[通过动态血糖监测证实钠-葡萄糖协同转运蛋白2抑制剂对两名1型糖尿病门诊患者的短期降糖效果]
J UOEH. 2020;42(4):359-364. doi: 10.7888/juoeh.42.359.
8
Sodium-glucose cotransporter 2 inhibitors combined with dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: a review of current clinical evidence and rationale.钠-葡萄糖协同转运蛋白2抑制剂联合二肽基肽酶-4抑制剂治疗2型糖尿病：当前临床证据及理论依据综述
Drug Des Devel Ther. 2017 Mar 21;11:923-937. doi: 10.2147/DDDT.S121899. eCollection 2017.
9
Positioning of sodium-glucose cotransporter-2 inhibitors in national and international guidelines.钠-葡萄糖协同转运蛋白2抑制剂在国内和国际指南中的定位
Med Clin (Barc). 2016 Nov;147 Suppl 1:49-53. doi: 10.1016/S0025-7753(17)30626-7.
10
Use of sodium-glucose cotransporter 2 inhibitors in older patients with type 2 diabetes mellitus.钠-葡萄糖共转运蛋白 2 抑制剂在 2 型糖尿病老年患者中的应用。
Geriatr Gerontol Int. 2018 Jan;18(1):108-114. doi: 10.1111/ggi.13149. Epub 2017 Sep 1.

引用本文的文献

1
The impact of sodium-glucose cotransporter-2 inhibitors on breast cancer and cancer-related mortality: a systematic review and meta-analysis of randomized controlled trials.钠-葡萄糖协同转运蛋白2抑制剂对乳腺癌及癌症相关死亡率的影响：一项随机对照试验的系统评价与荟萃分析
BMC Cancer. 2025 Jun 3;25(1):991. doi: 10.1186/s12885-025-14304-8.
2
Real-world evidence on the association of novel antidiabetic medication use with cancer risk and protective effects: a systematic review and network meta-analysis.新型抗糖尿病药物使用与癌症风险及保护作用关联的真实世界证据：一项系统综述和网状Meta分析。
Ther Adv Drug Saf. 2025 Apr 21;16:20420986251335214. doi: 10.1177/20420986251335214. eCollection 2025.
3
The Influence of Performance Status, Inflammation, and Nutrition on the Impact of SGLT2 Inhibitors on Cancer Outcomes.
体能状态、炎症和营养对SGLT2抑制剂对癌症结局影响的作用
Cancer Med. 2025 Mar;14(6):e70807. doi: 10.1002/cam4.70807.
4
Neuroendocrine tumors and diabetes mellitus: which treatment and which effect.神经内分泌肿瘤与糖尿病：何种治疗方法及何种效果。
Endocrine. 2025 Apr;88(1):36-50. doi: 10.1007/s12020-024-04149-9. Epub 2025 Jan 3.
5
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents.重新利用代谢调节剂：抗糖尿病药物作为抗癌剂。
Mol Biomed. 2024 Sep 28;5(1):40. doi: 10.1186/s43556-024-00204-z.
6
Unveiling the anticancer effects of SGLT-2i: mechanisms and therapeutic potential.揭示SGLT-2抑制剂的抗癌作用：机制与治疗潜力
Front Pharmacol. 2024 Mar 26;15:1369352. doi: 10.3389/fphar.2024.1369352. eCollection 2024.
7
SGLT2 Inhibitor Use and Risk of Breast Cancer Among Adult Women with Type 2 Diabetes.SGLT2 抑制剂在 2 型糖尿病成年女性中的使用与乳腺癌风险。
Drug Saf. 2024 Feb;47(2):125-133. doi: 10.1007/s40264-023-01373-6. Epub 2023 Dec 9.
8
SGLT-2 Inhibitors in Cancer Treatment-Mechanisms of Action and Emerging New Perspectives.SGLT-2抑制剂在癌症治疗中的作用机制及新出现的观点
Cancers (Basel). 2022 Nov 25;14(23):5811. doi: 10.3390/cancers14235811.
9
SGLT-2i and Risk of Malignancy in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials.SGLT-2i 与 2 型糖尿病恶性肿瘤风险：随机对照试验的荟萃分析。
Front Public Health. 2021 Jun 7;9:668368. doi: 10.3389/fpubh.2021.668368. eCollection 2021.
10
Diabetes, Antidiabetic Medications and Cancer Risk in Type 2 Diabetes: Focus on SGLT-2 Inhibitors.糖尿病、抗糖尿病药物与 2 型糖尿病的癌症风险：关注 SGLT-2 抑制剂。
Int J Mol Sci. 2021 Feb 7;22(4):1680. doi: 10.3390/ijms22041680.